Tomo Suga

448 total citations
15 papers, 238 citations indexed

About

Tomo Suga is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Tomo Suga has authored 15 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cancer Research. Recurrent topics in Tomo Suga's work include Effects of Radiation Exposure (4 papers), Pluripotent Stem Cells Research (3 papers) and Molecular Biology Techniques and Applications (3 papers). Tomo Suga is often cited by papers focused on Effects of Radiation Exposure (4 papers), Pluripotent Stem Cells Research (3 papers) and Molecular Biology Techniques and Applications (3 papers). Tomo Suga collaborates with scholars based in Japan, Australia and India. Tomo Suga's co-authors include Takashi Imai, Goro Chihara, Atsuko Ishikawa, Mayumi Iwakawa, Yuichi Michikawa, Kenichi L. Ishikawa, Tatsuya Ohno, Hitoshi Ishikawa, Yoshimi Shoji and Shingo Kato and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Tomo Suga

15 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomo Suga Japan 11 106 56 53 40 36 15 238
Yun Su China 12 176 1.7× 78 1.4× 26 0.5× 18 0.5× 26 0.7× 27 345
Zhilin Chen China 11 98 0.9× 42 0.8× 31 0.6× 21 0.5× 25 0.7× 32 319
David Wang United States 8 175 1.7× 32 0.6× 16 0.3× 37 0.9× 16 0.4× 20 271
Zhuoyu Li China 11 131 1.2× 38 0.7× 54 1.0× 17 0.4× 13 0.4× 30 407
Jiong Cai China 10 127 1.2× 38 0.7× 76 1.4× 9 0.2× 42 1.2× 48 306
Jiarong Cai China 13 256 2.4× 142 2.5× 9 0.2× 41 1.0× 38 1.1× 28 415
Faisal Ahmed United States 11 152 1.4× 16 0.3× 52 1.0× 16 0.4× 15 0.4× 20 333
Xinmei Li China 11 188 1.8× 85 1.5× 11 0.2× 47 1.2× 78 2.2× 19 313
Yifan Su China 11 116 1.1× 48 0.9× 6 0.1× 27 0.7× 22 0.6× 29 301
Xiaofang He China 10 187 1.8× 68 1.2× 149 2.8× 43 1.1× 65 1.8× 28 442

Countries citing papers authored by Tomo Suga

Since Specialization
Citations

This map shows the geographic impact of Tomo Suga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomo Suga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomo Suga more than expected).

Fields of papers citing papers by Tomo Suga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomo Suga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomo Suga. The network helps show where Tomo Suga may publish in the future.

Co-authorship network of co-authors of Tomo Suga

This figure shows the co-authorship network connecting the top 25 collaborators of Tomo Suga. A scholar is included among the top collaborators of Tomo Suga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomo Suga. Tomo Suga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Araki, Ryoko, Tomo Suga, Yuko Hoki, et al.. (2024). iPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms. Nature Communications. 15(1). 4946–4946. 1 indexed citations
2.
Kamimura, Satoshi, Tomo Suga, Yuko Hoki, et al.. (2021). Insertion/deletion and microsatellite alteration profiles in induced pluripotent stem cells. Stem Cell Reports. 16(10). 2503–2519. 2 indexed citations
3.
Araki, Ryoko, Yuko Hoki, Tomo Suga, et al.. (2020). Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency. Nature Communications. 11(1). 197–197. 26 indexed citations
4.
Daino, Kazuhiro, Atsuko Ishikawa, Tomo Suga, et al.. (2019). Mutational landscape of T-cell lymphoma in mice lacking the DNA mismatch repair gene Mlh1: no synergism with ionizing radiation. Carcinogenesis. 40(2). 216–224. 14 indexed citations
5.
Okonogi, Noriyuki, Daijiro Kobayashi, Tomo Suga, et al.. (2017). Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer. Oncology Letters. 15(1). 459–466. 20 indexed citations
6.
Mumbrekar, Kamalesh Dattaram, Bola Sadashiva Satish Rao, Shama Prasada Kabekkodu, et al.. (2016). Genetic Variants in CD44 and MAT1A Confer Susceptibility to Acute Skin Reaction in Breast Cancer Patients Undergoing Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 97(1). 118–127. 16 indexed citations
7.
Shibamoto, Yuta, Tomo Suga, Atsuko Ishikawa, et al.. (2011). Single Nucleotide Polymorphisms Associated with Risk of Adverse Skin Reactions to Radiation in Patients Undergoing Breast-conserving Therapy: Single-institution Analysis. International Journal of Radiation Oncology*Biology*Physics. 81(2). S757–S758. 1 indexed citations
8.
Michikawa, Yuichi, Tomo Suga, Atsuko Ishikawa, et al.. (2010). Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients. BMC Medical Genetics. 11(1). 123–123. 11 indexed citations
9.
Ishikawa, Atsuko, Tomo Suga, Yoshimi Shoji, et al.. (2010). Genetic Variants of NPAT-ATM and AURKA are Associated With an Early Adverse Reaction in the Gastrointestinal Tract of Patients With Cervical Cancer Treated With Pelvic Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1144–1152. 18 indexed citations
10.
Suga, Tomo, Mayumi Iwakawa, Hiroshi Tsuji, et al.. (2008). Influence of Multiple Genetic Polymorphisms on Genitourinary Morbidity After Carbon Ion Radiotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(3). 808–813. 22 indexed citations
11.
Michikawa, Yuichi, Keisuke Sugahara, Tomo Suga, et al.. (2008). In-gel multiple displacement amplification of long DNA fragments diluted to the single molecule level. Analytical Biochemistry. 383(2). 151–158. 7 indexed citations
12.
Michikawa, Yuichi, Tomo Suga, Izumi Matsumoto, et al.. (2008). Visible Genotype Sensor Array. Sensors. 8(4). 2722–2735. 10 indexed citations
13.
Ishikawa, Kenichi L., Atsuko Ishikawa, Kaori Yasuda, et al.. (2006). Gene expression profile changes correlating with radioresistance in human cell lines. International Journal of Radiation Oncology*Biology*Physics. 65(1). 234–245. 19 indexed citations
14.
Michikawa, Yuichi, Kenji Kinoshita, Keisuke Sugahara, et al.. (2006). Reliable and Fast Allele-Specific Extension of 3′-LNA Modified Oligonucleotides Covalently Immobilized on a Plastic Base, Combined with Biotin-dUTP Mediated Optical Detection. Analytical Sciences. 22(12). 1537–1545. 10 indexed citations
15.
Chihara, Goro, et al.. (1987). Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.. PubMed. 1. 423–43. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026